1) Cassandra Willyard (2021). How antiviral pill molnupiravir shot ahead in the COVID drug hunt: The Merck pill, which could become the first oral antiviral COVID treatment, forces the SARS-CoV-2 coronavirus to mutate itself to death. Nature News 08 October 2021, Free access: https://www.nature.com/articles/d41586-021-02783-1
2) Kyriazopoulou, E., Poulakou, G., Milionis, H. et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med (2021). https://doi.org/10.1038/s41591-021-01499-z Open access: https://www.nature.com/articles/s41591-021-01499-z
3) Raymund R. Razonablea et al. (2021). CasirivimabImdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19, EClinicalMedicine, Article in Press, Open access: https://www.thelancet.com/action/showPdf?pii=S2589-5370%2821%2900382-5